Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
Andrographolide (AGP), a naturally occurring bioactive compound, has been investigated as a lead compound in cancer drug development. Its multidimensional therapeutic effects have raised interest among medicinal chemists, which has led to extensive structural modification of the compound, resulting...
Saved in:
Main Authors: | Soo, Hon Liong, Quah, Shun Ying, Sulaiman, Ibrahim, Sagineedu, Sreenivasa Rao, Lim, Chee Woei, Stanslas, Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019
|
Online Access: | http://psasir.upm.edu.my/id/eprint/80553/1/ANDRO.pdf http://psasir.upm.edu.my/id/eprint/80553/ https://www.sciencedirect.com/science/article/pii/S1359644618302216 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Andrographolide as a template in the synthesis of new anticancer agents with potentially novel molecular targets
by: Stanslas, Johnson, et al.
Published: (2010) -
Andrographolide induces cell cycle arrest and apoptosis in PC-3 prostate cancer cells.
by: Hui, Chyn Wong, et al.
Published: (2011) -
Microarray-based identification of differentially expressed genes associated with andrographolide derivatives-induced resistance in colon and prostate cancer cell lines
by: Shun, Ying Quah, et al.
Published: (2021) -
Semisynthesis and in vitro anticancer activities of andrographolide analogues
by: Jada, Srinivasa Rao, et al.
Published: (2007) -
SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-kB nuclear binding in the A549 non-small cell lung cancer cell line
by: Lim, Jonathan Chee Woei, et al.
Published: (2015)